Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05833763 |
|---|---|
| Brief Title: | A Phase 2 Trial of GlOfitamab anD pIrtobrutinib in Mantle Cell Lymphoma Patients With Prior BTK Inhibitor Exposure. (GOlDiLOX) |
| First Submitted : | March 26, 2023 |
| First Submitted that Met QC Criteria : | April 18, 2023 |
| First Posted : | April 27, 2023 |
| Last Update Submitted that Met QC Criteria : | January 4, 2024 |
| Last Update Posted : | January 8, 2024 |